BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Acrolein

Acrolein Unsaturated three-carbon aldehyde.

300+ PubMed studies analyzed · Evidence Score: 39.2

Research Domains

Acrolein has been studied across 21 research domains including 🔬 Oncology, 🔬 Inflammation, 🧘 Stress & Anxiety, 🫁 Liver & Detox, 🔥 Metabolic. The primary research focus is 🔬 Oncology with 26% of studies addressing this area.

Similar Compounds by Shared Targets

The following compounds share molecular targets with Acrolein, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

Pipobroman
2 shared targets
Camphor
2 shared targets
Phenylglyoxal
2 shared targets
Carmustine
2 shared targets
diallyl
2 shared targets
iodoform
2 shared targets
Piperonyl
2 shared targets
salvin
2 shared targets
Physostigmine
2 shared targets
Physostigmine
2 shared targets
Loading evidence profile...

This evidence profile for Acrolein is generated deterministically from 300 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: current. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.